Konrad Zuzda: A Challenging Case of Heparin-Free VV-ECMO for High-Risk Airway Management
Konrad Zuzda, Trainees Committee Member of European Society of Anaesthesiology and Intensive Care, Researcher PhD Student at Medical University of Warsaw – MUW, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“We’ve described a challenging case of heparin-free VV-ECMO for high-risk airway management in advanced laryngeal tumour obstruction.
A 48-hour journey where pre-emptive cannulation under local anesthesia gave us the breathing room to perform a technically demanding tracheostomy safely.
Grateful to our multidisciplinary team for thinking creatively when conventional options simply weren’t viable.”
Title: Elective Heparin-Free Veno-Venous Extracorporeal Membrane Oxygenation for High-Risk Airway Management in Advanced Laryngeal Tumor Obstruction: A Case Report
Authors: Joanna Prokop, Konrad Zuzda, Wojciech Jan Górski, Miłosz Jankowski, Eliza Brożek-Mądry, Konstanty Szułdrzyński

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia